HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rima Al-Awar Selected Research

G-protein-coupled receptor kinase 6

1/2022Correction to "Design, Synthesis, and Characterization of 4-Aminoquinazolines as Potent Inhibitors of the G Protein-Coupled Receptor Kinase 6 (GRK6) for the Treatment of Multiple Myeloma".
12/2021Design, Synthesis, and Characterization of 4-Aminoquinazolines as Potent Inhibitors of the G Protein-Coupled Receptor Kinase 6 (GRK6) for the Treatment of Multiple Myeloma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rima Al-Awar Research Topics

Disease

18Neoplasms (Cancer)
10/2021 - 02/2011
6Leukemia
01/2019 - 02/2012
5Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2021 - 06/2015
3Multiple Myeloma
01/2022 - 11/2021
3Breast Neoplasms (Breast Cancer)
01/2021 - 04/2014
2Diffuse Intrinsic Pontine Glioma
10/2020 - 01/2020
2Glioblastoma (Glioblastoma Multiforme)
01/2016 - 11/2013
2Brain Neoplasms (Brain Tumor)
01/2016 - 11/2013
2Tics (Tic)
04/2014 - 02/2011
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2021
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
11/2021
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2021
1Lymphoma (Lymphomas)
01/2021
1Carcinogenesis
10/2018
1Leiomyosarcoma
03/2016
1Sarcoma (Soft Tissue Sarcoma)
03/2016
1Myeloid Leukemia (Leukemia, Myelocytic)
04/2013
1Neuroblastoma
02/2011

Drug/Important Bio-Agent (IBA)

6Proteins (Proteins, Gene)FDA Link
01/2021 - 01/2013
5Phosphotransferases (Kinase)IBA
12/2021 - 02/2011
4Lysine (L-Lysine)FDA Link
11/2021 - 03/2013
4MethyltransferasesIBA
11/2021 - 01/2013
4Pharmaceutical PreparationsIBA
10/2020 - 01/2012
3Histones (Histone)IBA
01/2019 - 01/2013
2G-protein-coupled receptor kinase 6IBA
01/2022 - 12/2021
2Histone MethyltransferasesIBA
10/2018 - 08/2015
2Small Interfering RNA (siRNA)IBA
04/2014 - 02/2011
1ErbB Receptors (EGF Receptor)IBA
11/2021
1Deubiquitinating EnzymesIBA
10/2021
1TNF Receptor-Associated Factor 1IBA
01/2021
1Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)IBA
01/2021
1Protein Kinase CIBA
01/2021
1Protein Kinases (Protein Kinase)IBA
01/2021
1Adenosine Triphosphate (ATP)IBA
01/2021
1Arginine (L-Arginine)FDA Link
01/2021
1TAK-243IBA
01/2021
1dipinacoline glutamateIBA
10/2020
1Phosphatidylinositols (Phosphatidylinositol)IBA
08/2020
1serotonin 5 receptorIBA
08/2020
1TOR Serine-Threonine KinasesIBA
08/2020
1TransferasesIBA
01/2019
1Carrier Proteins (Binding Protein)IBA
12/2018
1TetraspaninsIBA
01/2017
1Ethacridine (Ethacridine Lactate)IBA
11/2016
1poly ADP-ribose glycohydrolaseIBA
11/2016
1Erlotinib Hydrochloride (CP 358,774)FDA Link
11/2016
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2016
1Metformin (Glucophage)FDA LinkGeneric
04/2016
1Doxorubicin (Adriamycin)FDA LinkGeneric
03/2016
1dactolisibIBA
03/2016
1NVP-BKM120IBA
03/2016
1MTOR InhibitorsIBA
03/2016
1UNC1999IBA
01/2016
1Dexamethasone (Maxidex)FDA LinkGeneric
01/2016
1Histone Deacetylase InhibitorsIBA
01/2016
1Protein Isoforms (Isoforms)IBA
08/2015
1Biological ProductsIBA
07/2015
1Peptide Hydrolases (Proteases)FDA Link
06/2015
1Lapatinib (GW572016)FDA Link
04/2014
1Mitogen-Activated Protein KinasesIBA
04/2014
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
11/2013
1Adenosine (Adenocard)FDA LinkGeneric
04/2013
1Histone-Lysine N-MethyltransferaseIBA
04/2013
1histone H3 trimethyl Lys4IBA
01/2013
1EnzymesIBA
01/2013
1kinetin ribosideIBA
02/2012
1Protein MethyltransferasesIBA
01/2012
1S-Adenosylmethionine (Ademetionine)IBA
01/2012
1Caspase 2IBA
10/2011
1Irinotecan (Camptosar)FDA LinkGeneric
02/2011
1BI 6727IBA
02/2011
1Protein Kinase InhibitorsIBA
02/2011
1BI 2536IBA
02/2011
1Polo-Like Kinase 1IBA
02/2011

Therapy/Procedure

11Therapeutics
08/2020 - 02/2011
3Drug Therapy (Chemotherapy)
08/2020 - 04/2014